MSA is neuropathologically considered as one of the synucleinopathies due to the predominance of aggregated α-synuclein-positive cytoplasmic inclusions, classically localized in oligodendrocytes and termed glial cytoplasmic inclusions (GCIs) [3–5]. The gene discussed is SNCA; the disease is multiple system atrophy.